Doctor Ahmed A Kolkailah
University of Texas Southwestern Medical Center, Dallas (United States of America)
Effects of once-weekly semaglutide on coronary outcomes in patients with type 2 diabetes mellitus with or at high risk for cardiovascular disease: insights from the SUSTAIN-6 trial
Event: ESC Preventive Cardiology 2022
Topic: Pharmacotherapy
Session: Rapid fire abstracts session 1 - Secondary Prevention and Rehabilitation
ESC 365 is supported by
